Skip to content

Effect of dry ziziphus jujube in diabetic overweight or obese subjects

Effect of dry ziziphus jujube fruit on fasting blood glucose, serum insulin, lipid profiles, oxidative stress, inflammatory factors, serum fructose amine, and glycation end product in type 2 diabetic patients with obesity and overweight

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20181210041913N1
Enrollment
44
Registered
2019-08-14
Start date
2019-09-06
Completion date
Unknown
Last updated
2019-10-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Type 2 diabetes. Condition 2: Obesity. Diabetes mellitus due to underlying condition Overweight and obesity

Interventions

Intervention 1: Intervention group: They will receive energy balanced diet + 30 g/day dry ziziphus jujube once a day for 10 weeks. Energy balanced diet will be considered for Individuals based on food

Sponsors

Shahid Beheshti University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
35 Years to 60 Years

Inclusion criteria

Inclusion criteria: Agreement to participate in the study and completing informed consent form Aged 35-65 years old The duration of the disease should be between 1 to 10 years Fasting blood glucose and 2-h blood glucose should be less than 126 and 200 mg / dl, respectively. Body mass index=25 kg/m2 Patients who take only oral medication (not insulin) to control diabetes.

Exclusion criteria

Exclusion criteria: having allergy to dry jujube using of alcohol, opioids, and anti-inflammatory drugs. using of multi-vitamin mineral supplements, administration of clozapine, theophylline, caffeine, fennetin and tacrin. Pregnant and lactating Women

Design outcomes

Primary

MeasureTime frame
Serum concentrations of blood glucose. Timepoint: Before the intervention and 10 weeks after the intervention. Method of measurement: Enzymatic method.;Serum concentrations of total cholesterol. Timepoint: Before the intervention and 10 weeks after the intervention. Method of measurement: Enzymatic method.;Serum concentrations of triglyceride. Timepoint: Before the intervention and 10 weeks after the intervention. Method of measurement: Enzymatic method.;Low density lipoprotein- cholesterol. Timepoint: Before the intervention and 10 weeks after the intervention. Method of measurement: Enzymatic method.;High density lipoprotein- cholesterol. Timepoint: Before the intervention and 10 weeks after the intervention. Method of measurement: Enzymatic method.

Secondary

MeasureTime frame
Serum concentration of Insulin. Timepoint: Before the intervention and 10 weeks after the intervention. Method of measurement: ELISA method.;Serum concentration of malondialdehyde. Timepoint: Before the intervention and 10 weeks after the intervention. Method of measurement: Colorimetric method.;Serum concentration of Carboxy-methyl lysine. Timepoint: Before the intervention and 10 weeks after the intervention. Method of measurement: ELISA method.;Serum concentration of Interleukin-6. Timepoint: Before the intervention and 10 weeks after the intervention. Method of measurement: ELISA method.;Serum concentration of hs-CRP. Timepoint: Before the intervention and 10 weeks after the intervention. Method of measurement: ELISA method.;Serum concentration of fructoseamine. Timepoint: Before the intervention and 10 weeks after the intervention. Method of measurement: ELISA method.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactHossein Farhadnejad

Shahid Beheshti University of Medical Sciences

hosein.farhadnejad@gmail.com+98 21 2235 7484

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 18, 2026